Bayer CropScience is a world leader in the areas of crop protection pest control seeds and plant biotechnology. The Company is engaged in `Agri Care' business which primarily includes manufacture sale ...

Bayer CropScience is a world leader in the areas of crop protection, pest control, seeds and plant biotechnology. The Company is engaged in Agri Care business which primarily includes manufacture ...

Several states are trying to phase out the use of pesticides containing per- and polyfluoroalkyl substances (PFAS), long-lasting chemicals linked to serious health risks including cancer, liver damage ...

Attention lawn lovers! Do you want to maintain a healthy and pest-free lawn all year round? Are you tired of those pesky insects ruining your peaceful outdoor haven? Fear not, because we have rounded ...

Though there are 2 ideal seasons (spring and fall) to apply weed and feed, each of them has different requirements. For example, the best weed and feed for fall should provide your lawn with enough ...

24 Jul, 1993-1:1 For every 1 share held; Holder will receive 1 bonus shares. 05 Oct, 1987-1:1 For every 1 share held; Holder will receive 1 bonus shares. 08 Aug, 1977-1:1 For every 1 share held ...

The coming year will see a continuation of some long-running mass tort litigation based on traditional product liability theories of toxic exposure, and potentially the rise of novel legal ...

(Beyond Pesticides, December 18, 2024) A bombshell investigation conducted by Canada’s National Observer finds that Bayer, which acquired the Monsanto chemical company in 2018, colluded with ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Larotrectinib sulfate is under clinical development by Bayer and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II drugs for Colorectal Cancer have a 25% phase transition ...